Example: biology
SUMMARY OF PRODUCT CHARACTERISTICS
This product is intended for use in children. Nonetheless, safety information is provided with respect to adult health issues such as liver disease, pregnancy and lactation, to allow full access to all
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
SUMMARY OF PRODUCT CHARACTERISTICS
extranet.who.intArtesunate 60 mg for injection WHOPAR part 4 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 . SUMMARY OF PRODUCT CHARACTERISTICS
Reproductive, Newborn And Child Health Policy
extranet.who.intmortality, maternal health, and HIV and AIDs respectively, will have a direct or indirect impact on the reproductive health of Sierra Leone. At the World Summit in September 2005, the ... Reproductive, Newborn, and Child Health (RNCH) section of the BPEHS contains components, interventions, and services
Anexo 1 Buenas prácticas de la OMS para …
extranet.who.int2 Consideraciones generales El Comité de Expertos sobre Especificaciones para Productos Farmacéuticos de la OMS adoptó en 1999 las guías tituladas Buenas prácticas para laboratorios nacionales de control farmacéutico de la OMS, que fueron publicadas como Anexo 3 de la Serie de Informes Técnicos de la OMS, No. 902, 2002.
GOOD DOCUMENTATION AND QUALITY …
extranet.who.intGOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme
6. Process control— introduction to quality control
extranet.who.intLaboratory Quality Management System 73 6-1: Introduction QC for varying methods To avoid confusion, the term "quality control" will be used here to mean use
Vaccine Handling BCG - World Health Organization
extranet.who.intEnsuring the quality of vaccines at country level: Guidelines for health staff At the higher levels of the cold chain, i.e. at the national (central) and
Guidelines: Saturated fatty acid and trans-fatty acid ...
extranet.who.intthe WHO Nutrition Guidance Expert Advisory Group (NUGAG) Subgroup on Diet and Health – participated in the WHO guideline development meetings.
Varicella Contraindications - WHO/OMS: Extranet …
extranet.who.intContraindications Varicella vaccines (WHO position paper) In immunocompromised persons, including patients with advanced HIV infection, varicella vaccination is currently contraindicated for fear of
Pneumococcal Contraindications - WHO/OMS: …
extranet.who.intContraindications Pneumococcal vaccines (WHO position paper) There are no absolute contraindications to vaccination with pneumococcal polysaccharide vaccine except for an anaphylactic reaction to the previous
Contraindications BCG - WHO/OMS: Extranet Systems
extranet.who.intRubella vaccines (WHO position paper) Rubella vaccination should be avoided in pregnancy because of the theoretical, but never demonstrated, teratogenic risk.
Related documents
1. SUMMARY OF PRODUCT CHARACTERISTICS
fs-1.5mpublishing.com1. summary of product characteristics registration file / december 2010 m + pac 1. summary of product characteristics . 1. name of the veterinary medicinal product
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ether.stanford.eduSUMMARY OF PRODUCT CHARACTERISTICS. 2 1. NAME OF THE MEDICINAL PRODUCT Bridion 100mg/mLsolution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1mLcontains sugammadex sodium equivalent to 100mg sugammadex. Each vial of 2mLcontains sugammadex sodium equivalent to 200mg sugammadex.
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ec.europa.euSUMMARY OF PRODUCT CHARACTERISTICS . 2 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ec.europa.euSummary of the safety profile In five large longterm clinical tr ials over 2,500 patients have received treatment with Victoza alone or in combination with metformin, a sulfonylurea (with or without metformin) or metformin plus
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
pp.jazzpharma.com2 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any
SUMMARY OF PRODUCT CHARACTERISTICS - …
clonmelhealthcare.ieSUMMARY OF PRODUCT CHARACTERISTICS . 1 NAME OF THE MEDICINAL PRODUCT Prednisolone 1mg Tablets . 2 QUALITATIVE AND QUANTITATIVE COMPOSITION . Each tablet contains 1 mg prednisolone.
SUMMARY OF PRODUCT CHARACTERISTICS - …
db.cbg-meb.nlSummary of Product Characteristics (English version)_____ 4.6 Pregnancy and lactation Pregnancy The available data on the use of budesonide in pregnancy in women are not sufficient to evaluate the safety of the product. Foetal malformations were observed in animal studies.
SUMMARY OF PRODUCT CHARACTERISTICS - …
db.cbg-meb.nlWELLBUTRIN XR Summary of Product Characteristics 1. NAME OF THE MEDICINAL PRODUCT WELLBUTRIN XR 150 mg modified release tablets. WELLBUTRIN XR 300 mg modified release tablets.
SUMMARY OF PRODUCT CHARACTERISTICS
cdsco.nic.inSummary of Product Characteristics lactating women may be considered after careful evaluation of the benefits and risks in case of a medical emergency or an epidemic.
SUMMARY OF PRODUCT CHARACTERISTICS
pp.jazzpharma.comcontinued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed (see below).